These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23019580)

  • 41. Profiling of CD4+ T cells with epigenetic immune lineage analysis.
    Janson PC; Linton LB; Bergman EA; Marits P; Eberhardson M; Piehl F; Malmström V; Winqvist O
    J Immunol; 2011 Jan; 186(1):92-102. PubMed ID: 21131423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Associations between the expression of epigenetically regulated genes and the expression of DNMTs and MBDs in systemic lupus erythematosus.
    Balada E; Castro-Marrero J; Felip L; Ordi-Ros J; Vilardell-Tarrés M
    PLoS One; 2012; 7(9):e45897. PubMed ID: 23029299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of IL-17 in human CCR6+ effector memory T cells.
    Liu H; Rohowsky-Kochan C
    J Immunol; 2008 Jun; 180(12):7948-57. PubMed ID: 18523258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel intronic cAMP response element modulator (CREM) promoter is regulated by activator protein-1 (AP-1) and accounts for altered activation-induced CREM expression in T cells from patients with systemic lupus erythematosus.
    Rauen T; Benedyk K; Juang YT; Kerkhoff C; Kyttaris VC; Roth J; Tsokos GC; Tenbrock K
    J Biol Chem; 2011 Sep; 286(37):32366-72. PubMed ID: 21757709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus.
    Fan W; Liang D; Tang Y; Qu B; Cui H; Luo X; Huang X; Chen S; Higgs BW; Jallal B; Yao Y; Harley JB; Shen N
    Arthritis Rheum; 2012 Nov; 64(11):3715-25. PubMed ID: 22736314
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV.
    Juang YT; Wang Y; Solomou EE; Li Y; Mawrin C; Tenbrock K; Kyttaris VC; Tsokos GC
    J Clin Invest; 2005 Apr; 115(4):996-1005. PubMed ID: 15841182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway.
    Shin HC; Benbernou N; Esnault S; Guenounou M
    Cytokine; 1999 Apr; 11(4):257-66. PubMed ID: 10328864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Signals from CD28 induce stable epigenetic modification of the IL-2 promoter.
    Thomas RM; Gao L; Wells AD
    J Immunol; 2005 Apr; 174(8):4639-46. PubMed ID: 15814687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TNFAIP3 downregulation mediated by histone modification contributes to T-cell dysfunction in systemic lupus erythematosus.
    Zhao H; Wang L; Luo H; Li QZ; Zuo X
    Rheumatology (Oxford); 2017 May; 56(5):835-843. PubMed ID: 28158872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Defining CD4 T cell memory by the epigenetic landscape of CpG DNA methylation.
    Komori HK; Hart T; LaMere SA; Chew PV; Salomon DR
    J Immunol; 2015 Feb; 194(4):1565-79. PubMed ID: 25576597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells.
    Pipkin ME; Sacks JA; Cruz-Guilloty F; Lichtenheld MG; Bevan MJ; Rao A
    Immunity; 2010 Jan; 32(1):79-90. PubMed ID: 20096607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The catalytic subunit of protein phosphatase 2A (PP2Ac) promotes DNA hypomethylation by suppressing the phosphorylated mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase (MEK)/phosphorylated ERK/DNMT1 protein pathway in T-cells from controls and systemic lupus erythematosus patients.
    Sunahori K; Nagpal K; Hedrich CM; Mizui M; Fitzgerald LM; Tsokos GC
    J Biol Chem; 2013 Jul; 288(30):21936-44. PubMed ID: 23775084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-29b contributes to DNA hypomethylation of CD4+ T cells in systemic lupus erythematosus by indirectly targeting DNA methyltransferase 1.
    Qin H; Zhu X; Liang J; Wu J; Yang Y; Wang S; Shi W; Xu J
    J Dermatol Sci; 2013 Jan; 69(1):61-7. PubMed ID: 23142053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased expression of IL-2 in central and effector CD4 memory cells during progression to AIDS in rhesus macaques.
    Koopman G; Niphuis H; Newman W; Kishimoto TK; Maino VC; Heeney JL
    AIDS; 2001 Dec; 15(18):2359-69. PubMed ID: 11740186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance.
    Koga T; Hedrich CM; Mizui M; Yoshida N; Otomo K; Lieberman LA; Rauen T; Crispín JC; Tsokos GC
    J Clin Invest; 2014 May; 124(5):2234-45. PubMed ID: 24667640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The cyclic adenosine 5'-monophosphate response element modulator suppresses IL-2 production in stimulated T cells by a chromatin-dependent mechanism.
    Tenbrock K; Juang YT; Tolnay M; Tsokos GC
    J Immunol; 2003 Mar; 170(6):2971-6. PubMed ID: 12626549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
    Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
    Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cholera toxin enhances interleukin-17A production in both CD4
    Tsai HC; Velichko S; Lee S; Wu R
    Immunology; 2018 Jul; 154(3):500-509. PubMed ID: 29377102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epigenetic Reprogramming in Naive CD4+ T Cells Favoring T Cell Activation and Non-Th1 Effector T Cell Immune Response as an Early Event in Lupus Flares.
    Coit P; Dozmorov MG; Merrill JT; McCune WJ; Maksimowicz-McKinnon K; Wren JD; Sawalha AH
    Arthritis Rheumatol; 2016 Sep; 68(9):2200-9. PubMed ID: 27111767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus.
    Solomou EE; Juang YT; Gourley MF; Kammer GM; Tsokos GC
    J Immunol; 2001 Mar; 166(6):4216-22. PubMed ID: 11238674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.